BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, March 21, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 29, 2010
View Archived Issues
Snapshots: New strategies for treating Alzheimer's disease
Read More
LC-06 and LC-08 inhibit angiogenesis and tumor survival in vivo
Read More
Lu-AA-42202 shows favorable preclinical pharmacological profile
Read More
SAR-153192 suppresses tumor growth in vivo and continues evaluation in phase I trial
Read More
Innate Pharma begins phase II IPH-2101 trial in smoldering multiple myeloma
Read More
Chugai Pharma reports developmental highlights of Q3
Read More
New inhibitors of galectin-1 and galectin-3 discovered
Read More
GlaxoSmithKline presents new P2X7 receptor antagonists
Read More
New inhibitors of E-selectin and chemokine CXCR4 receptor claimed
Read More
Merrion and Rebel Pharma enter into feasibility and option agreement
Read More
Neuren Pharma develops oral formulation of NNZ-2566
Read More
New antagonists claimed of transient receptor potential TRPM8 channel
Read More
Profectus BioSciences divulges new NF-kappa-B inhibitors
Read More
Katholieke Universiteit Leuven discloses new HIV-1 reverse transcriptase substrates
Read More
MAA submitted to EMA for taliglucerase alfa in Gaucher's disease
Read More
Pharming reports topline phase II data on Ruconest in asymptomatic HAE
Read More
Tribunal finds Johnson & Johnson in breach of agreement with Basilea for ceftobiprole
Read More
Takara Bio licenses methylation-specific PCR technology from MDxHealth
Read More
Selcia and Gilead to continue liver disease drug discovery collaboration
Read More
Takeda applies to change Leuplin dosage and administration for CPP in Japan
Read More
Xention raises funds to support atrial fibrillation programs
Read More
Johnson & Johnson reports R&D highlights of Q3
Read More
AMAG updates Feraheme label following reports of hypersensitivity reactions
Read More
Amarin's pivotal phase III MARINE trial of AMR-101 meets primary endpoints
Read More
Affymax and Takeda to submit NDA for Hematide to FDA
Read More
